Table 3.
Somatic mutations in mapkapk-5 in cancer tissues
| Primary tissue | Unique mutated samples | % mutated | Total unique samples | Mutation data | references |
|---|---|---|---|---|---|
| bilary tract |
0 |
0% |
2 |
|
|
| breast |
0 |
0% |
201 |
|
|
| CNS |
0 |
0% |
477 |
|
|
| haematopoietic and lymphoid tissue |
0 |
0% |
27 |
|
|
| kidney |
0 |
0% |
28 |
|
|
| large intestine |
0 |
0% |
42 |
|
|
| lung |
2 |
1% |
171 |
c.406 C > T: L136L |
[49] |
| c.450 G > A: K150K |
[49] |
||||
| c.1371A > G: E457E |
[49] |
||||
| melanoma |
1 |
4% |
25 |
c.890 G > A: L297E |
[54] |
| ovary |
1 |
1% |
85 |
c.660 + 2 T > A: intronic mutation |
[50] |
| pancreas |
0 |
0% |
31 |
|
|
| pleura |
0 |
0% |
1 |
|
|
| prostate |
0 |
0% |
58 |
|
|
| salivary gland |
0 |
0% |
9 |
|
|
| skin |
0 |
0% |
6 |
|
|
| stomach |
0 |
0% |
34 |
|
|
| testis |
0 |
0% |
13 |
|
|
| upper aerodigestive tract |
0 |
0% |
19 |
|
|
| urinary tract | 0 | 0% | 2 |